Synopsys (NASDAQ:SNPS – Get Rating) is scheduled to release its earnings data after the market closes on Wednesday, May 18th. Analysts expect Synopsys to post earnings of $1.80 per share for the quarter. Individual that are interested in registering for the company’s earnings conference call can do so using this link.
Synopsys (NASDAQ:SNPS – Get Rating) last released its quarterly earnings results on Wednesday, February 16th. The semiconductor company reported $1.78 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.79 by ($0.01). The company had revenue of $1.27 billion during the quarter, compared to analysts’ expectations of $1.27 billion. Synopsys had a net margin of 20.18% and a return on equity of 16.74%. Synopsys’s revenue was up 30.9% on a year-over-year basis. During the same period last year, the firm posted $1.03 earnings per share. On average, analysts expect Synopsys to post $6 EPS for the current fiscal year and $6 EPS for the next fiscal year.
NASDAQ:SNPS opened at $270.51 on Wednesday. Synopsys has a fifty-two week low of $225.02 and a fifty-two week high of $377.60. The company has a 50 day moving average price of $305.19 and a 200 day moving average price of $322.74. The stock has a market capitalization of $41.41 billion, a P/E ratio of 46.80, a PEG ratio of 3.01 and a beta of 1.21.
In other news, CEO Chi-Foon Chan sold 12,570 shares of the company’s stock in a transaction on Friday, February 18th. The shares were sold at an average price of $289.25, for a total transaction of $3,635,872.50. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CRO Joseph W. Logan sold 86,973 shares of the firm’s stock in a transaction dated Friday, February 18th. The shares were sold at an average price of $289.40, for a total transaction of $25,169,986.20. The disclosure for this sale can be found here. 1.20% of the stock is currently owned by company insiders.
Several large investors have recently made changes to their positions in SNPS. Vident Investment Advisory LLC grew its holdings in shares of Synopsys by 11.4% in the 4th quarter. Vident Investment Advisory LLC now owns 3,983 shares of the semiconductor company’s stock worth $1,468,000 after acquiring an additional 409 shares during the period. Neo Ivy Capital Management purchased a new position in shares of Synopsys in the fourth quarter valued at $166,000. HB Wealth Management LLC acquired a new position in shares of Synopsys during the 4th quarter worth $230,000. Colony Group LLC purchased a new stake in shares of Synopsys in the 4th quarter worth about $239,000. Finally, Forum Financial Management LP acquired a new stake in Synopsys in the 4th quarter valued at about $340,000. 84.71% of the stock is currently owned by institutional investors and hedge funds.
About Synopsys (Get Rating)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. The company offers Fusion Design Platform that provides digital design implementation solutions; Verification Continuum Platform that provides virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
- Get a free copy of the StockNews.com research report on Synopsys (SNPS)
- XPO Logistics Is A Logical Choice For Investors
- 3 Online Education Stocks Investors Should Study
- If PetMeds Is A Good Buy There Will Be A Better Signal
- Insiders Buy Occidental Petroleum Ahead Of Q1 Earnings
- High-Yield Deep-Value LCI Industries Exceeds All Expectations
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.